At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 5 enrolled
Drug / intervention
Dendritic Cells Pulsed with HIV antigensbiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Immune Responses to Antigen-Bearing Dendritic Cells in HIV-Infected Individuals
National Institute of Allergy and Infectious Diseases (NIAID)·interventional·Posted Apr 14, 2003·Updated Aug 27, 2007
In Brief
A Phase 1 clinical trial evaluating Dendritic Cells Pulsed with HIV antigens for HIV Infections. Completed, enrolled 5 participants across 1 site.
Detailed Summary
The aim of this trial is to find out if immune responses to HIV can be boosted in individuals who start medicines soon after being infected. If immune responses can be boosted to the virus, this may allow the body to control HIV without the need for medications. This study is designed to test a new strategy for boosting immune responses to HIV and to evaluate if these responses allow people to have control of HIV without medicines.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2000
First PostedApr 2003
TodayJul 2026
First PostedApr 14, 2003
Enrollment StartNov 1, 2000
TodayJul 2, 2026
Posted 23.2 years ago
Interventions
Dendritic Cells Pulsed with HIV antigensbiological